The legacy effect: 4.5 years of a chlorthalidone-based antihypertensive regimen reduces cardiovascular mortality and prolongs cardiovascular disease-free survival at 22 years for older patients with isolated systolic hypertension

Evid Based Med. 2012 Dec;17(6):183-4. doi: 10.1136/ebmed-2012-100677. Epub 2012 Apr 17.
No abstract available

Publication types

  • Comment